BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 28, 2025; 31(40): 112637
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.112637
Comprehensive microbial and clinical profiling of functional constipation: A stratified comparative study of age and constipation subtype
Hui-Ting Zhu, Hui-Fen Wang, Qin Zhang, Ju-Fang Bai, Miao Wang, Shi-Yu Du, Yan-Li Zhang
Hui-Ting Zhu, Hui-Fen Wang, Qin Zhang, Miao Wang, Shi-Yu Du, Yan-Li Zhang, Department of Gastroenterology, China-Japan Friendship Hospital, Beijing 100029, China
Ju-Fang Bai, Department of Gastroenterology, Qinghai Provincial People’s Hospital, Xining 810007, Qinghai Province, China
Co-first authors: Hui-Ting Zhu and Hui-Fen Wang.
Co-corresponding authors: Shi-Yu Du and Yan-Li Zhang.
Author contributions: Zhu HT, Wang HF, Zhang YL and Du SY contributed to the study conception and design; Zhu HT and Wang HF contributed to material preparation and analysis; Zhu HT, Wang HF, Zhang Q and Bai JF contributed to data collection and analysis; Zhu HT written the first draft of the manuscript; Zhu HT, Wang HF, Zhang Q, Bai JF, Wang M, Du SY, Zhang YL commented on previous versions of the manuscript; all authors read and approved the final manuscript.
Supported by the China Medical and Health Development Foundation, No. 2022-HX-76; and China-Japan Friendship Hospital High-level Hospital Clinical Business Expenses Special Project, No. 2023-NHLHCRF-YYPPLC-ZR-19.
Institutional review board statement: The study protocol was reviewed and approved by the Ethics Committee of the China-Japan Friendship Hospital (No. 2022-KY-233).
Clinical trial registration statement: This study is registered at http://www.clinicaltrials.gov/. The registration identification number is No. NCT06339697.
Informed consent statement: All participants provided written informed consent.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.
Data sharing statement: The original contributions presented in the study are included in the Supplementary material; further inquiries can be directed to the corresponding authors.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yan-Li Zhang, MD, Professor, Department of Gastroenterology, China-Japan Friendship Hospital, No. 2 East Yinghua Street, Chaoyang District, Beijing 100029, China. 13521234067@163.com
Received: August 4, 2025
Revised: August 26, 2025
Accepted: September 23, 2025
Published online: October 28, 2025
Processing time: 87 Days and 3.5 Hours
Abstract
BACKGROUND

Gut microbiota dysbiosis plays a central role in the pathogenesis of functional constipation (FC), but clinical treatment has shown uneven efficacy through methods of regulating intestinal flora. Most existing studies have concentrated on overall case-control comparisons, with limited stratification by age or constipation subtype. Knowledge of how these factors shape gut microbiota composition remains inadequate, constraining the development of effective personalized microbiota-based interventions.

AIM

To characterize gut microbiota profiles by age and constipation subtype and identify factors associated with microbial composition in FC.

METHODS

Ninety-two patients with FC completed questionnaires and underwent anorectal manometry and gastrointestinal transit tests; stool samples were collected for 16S rRNA gene sequencing. Stool samples alone were collected from 34 healthy controls. Patients with FC were categorized into age groups (young, middle-aged, and older) and classified into normal-transit constipation, slow-transit constipation (STC), defecatory disorder (DD), and mixed constipation subtypes. Gut microbial compositions across age groups and constipation subtypes were compared, and their correlations with clinical parameters were investigated.

RESULTS

The young group demonstrated significantly higher anal resting and squeeze pressures than the middle-aged and the older groups. Microbial richness and diversity were substantially lower in the older group than in middle-aged and young groups. Gut microbiota in the young group was predominantly enriched in taxa increasing sphincter tone and inhibiting intestinal peristalsis; the older group featured abundances of short-chain fatty acid-producing, beneficial taxa. The middle-aged group showed an enrichment of pro-inflammatory and pathogenic bacteria. Microbial richness and diversity were higher in STC than in the DD group. Moreover, STC group was enriched in taxa associated with slower peristalsis; DD group showed enrichment of motility-promoting taxa.

CONCLUSION

Significant differences in microbial composition and function were observed across age groups and constipation subtypes in FC, suggesting underlying pathophysiological heterogeneity and providing a basis for precision diagnosis and treatment.

Keywords: Gut microbiota; Functional constipation; Gastrointestinal disorder; Microbial diversity; Age-related differences

Core Tip: This study highlights the distinct gut microbiota profiles associated with age and constipation subtypes in patients with functional constipation (FC). Using 16S rRNA sequencing, we found significant age-related differences in microbial diversity and composition, with older adults exhibiting reduced richness and beneficial taxa. Constipation subtypes also showed distinct microbial patterns, with slow-transit constipation enriched in taxa linked to reduced motility and defecatory disorder characterized by motility-promoting microbes. These findings underscore the pathophysiological heterogeneity of FC and support the development of age- and subtype-specific microbiota-targeted therapies for precision diagnosis and treatment.